Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Kindbody is a fertility clinic network and family-building benefits provider for employers.
Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
VivoSense is an advancing clinical research with wearable sensor solutions.
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Willow is a women's healthcare company that develops pumping bras and breast pumps for women.
Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.
Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
Perceptive Advisors has invested in 226 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 30 different industry categories.
Among tracked funding rounds, Blueprint Medicines received $1.3B in a Post-IPO Equity round. Perceptive Advisors's total known invested capital is $30.3B.
Perceptive Advisors's average investment size is $134.2M across its portfolio of 226 companies.
Recent Perceptive Advisors portfolio additions include AsclepiX Therapeutics, Black Diamond Therapeutics, Zentalis Pharmaceuticals, Kindbody, Juno Diagnostics. These companies were founded in 2020 or later.